Skip to main content
. 2022 Sep 6;3:974904. doi: 10.3389/fpain.2022.974904

Table 3.

Difference in current practice and a no screening trial strategy from 2020/21 to 2024/25.

Year 2020/21 2021/22 2022/23 2023/24 2024/25
No. patients with SCS 619 640 663 687 711
No. patients with a screening trial 619 640 663 687 711
No. patients with unsuccessful screening trial 66 68 71 73 76
Cost difference between current practice and no screening trial (per patient ~£700) £433,189 £448,534 £464,421 £480,872 £497,905

SCS, spinal cord stimulation.